Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03793361
Title Phase II Study of Regorafenib as Maintenance Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Oscar Lambret
Indications

leiomyosarcoma

synovial sarcoma

sarcoma

Therapies

Regorafenib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.